{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:03:01Z","timestamp":1759482181572},"reference-count":6,"publisher":"BMJ","issue":"6309","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1982,1,9]]},"DOI":"10.1136\/bmj.284.6309.83-a","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T15:00:59Z","timestamp":1238684459000},"page":"83-84","source":"Crossref","is-referenced-by-count":25,"title":["Retroperitoneal fibrosis associated with metoprolol."],"prefix":"10.1136","volume":"284","author":[{"given":"J","family":"Thompson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D G","family":"Julian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"76","article-title":"Analgesic abuse, ureteric obstruction and retroperitoneal fibrosis","volume":"ii:","author":"Lewis, C.T.; Molland, E.A.; Marshall, V.R.; Tresidder, G.C.; Blandy, J.P.","year":"1975","unstructured":"Lewis CT, Molland EA, Marshall VR, Tresidder GC, Blandy JP. Analgesic abuse, ureteric obstruction and retroperitoneal fibrosis. Br MedJ 1975;ii:76-8.","journal-title":"Br MedJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1056\/NEJM196401092700202","article-title":"Methysergide for prevention of headache: experience in 500 patients over 3 years","volume":"270","author":"Graham, JR","year":"1964","unstructured":"Graham JR. Methysergide for prevention of headache: experience in 500 patients over 3 years. N EnglJ3 Med 1964;270:67-72.","journal-title":"N EnglJ3 Med"},{"key":"ref_3","first-page":"864","article-title":"Retroperitoneal fibrosis associated with atenolol. Br MedJ3","volume":"280","author":"Johnson, J.N.; McFarland, J.B.","year":"1980","unstructured":"Johnson JN, McFarland JB. Retroperitoneal fibrosis associated with atenolol. Br MedJ3 1980;280:864."},{"key":"ref_4","first-page":"1459","article-title":"Oxprenolol and retroperitoneal fibrosis. Br MedJ3","volume":"281","author":"McCluskey, D.R.; Donaldson, R.A.; McGeown, M.G.","year":"1980","unstructured":"McCluskey DR, Donaldson RA, McGeown MG. Oxprenolol and retroperitoneal fibrosis. Br MedJ3 1980;281:1459-60."},{"key":"ref_5","first-page":"334","article-title":"Hepatitis B antigen inhibitor in human faeces and intestinal mucosa. Br Med J'","volume":"ii:","author":"Piazza, M.; Di Stasio, G.; Maio, G.; Marzano, L.A.","year":"1973","unstructured":"Piazza M, Di Stasio G, Maio G, Marzano LA. Hepatitis B antigen inhibitor in human faeces and intestinal mucosa. Br Med J' 1973;ii: 334-7."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/oxfordjournals.aje.a112894","article-title":"Epidemiologic nomenclature for hepatitis B virus transmission","volume":"l:","author":"Mosley, J.W.","year":"1980","unstructured":"Mosley JW. Epidemiologic nomenclature for hepatitis B virus transmission. Am Y Epidemiol 1980;l:261-2.","journal-title":"Am Y Epidemiol"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.284.6309.83-a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T16:08:10Z","timestamp":1601050090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.284.6309.83-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,1,9]]},"references-count":6,"journal-issue":{"issue":"6309","published-print":{"date-parts":[[1982,1,9]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.284.6309.83-a","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,1,9]]}}}